1. Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies;Alexopoulos;Eur J Intern Med,2022
2. Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants;Lippi;Clin Chem Lab Med,2021
3. Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant;Springer;Microbiol Spectr,2022
4. Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster;Favresse;J Med Virol,2022
5. The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization;Lippi;Int J Infect Dis,2022